Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study

Background: Immunotherapy has completely changed the treatment of solid tumors. Although immune checkpoint inhibitors (ICIs) seem to be an appealing alternative to chemotherapy, especially in elderly patients, due to a more tolerable toxicity profile, they can lead to a peculiar variety of immune-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Paderi, Agnese, Fancelli, Sara, Caliman, Enrico, Pillozzi, Serena, Gambale, Elisabetta, Mela, Marinella Micol, Doni, Laura, Mazzoni, Francesca, Antonuzzo, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395507/
https://www.ncbi.nlm.nih.gov/pubmed/34449588
http://dx.doi.org/10.3390/curroncol28050283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395507/
https://www.ncbi.nlm.nih.gov/pubmed/34449588
http://dx.doi.org/10.3390/curroncol28050283

Ejemplares similares